News | August 13, 2007

C4 Predicts Stroke in Patients with CAD

August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.

"What we have shown," lead investigator Dr. Erdal Cavusoglu told Reuters Health, "is that the complement components C3 and C4 were independent predictors of the future development of stroke in a broad and heterogenous population of patients who were referred for coronary angiography. C4 seemed slightly stronger than C3."

In the July 15th issue of the American Journal of Cardiology, Dr. Cavusoglu of Bronx Veterans Affairs Medical Center, New York and colleagues note that there is some data in the literature on C3 in prediction of stroke, but none for C4.

To investigate further, the researchers studied 389 men referred for angiography for a variety of indications.

During 24 months of follow-up, there were 23 strokes and elevated baseline C4 was an independent risk factor for such an event (hazard ratio 1.57).

Stroke-free survival in subjects whose C4 levels were at or below the median was 96.1 percent. For those with higher levels, it was 90.1 percent.

The researchers also found that established markers such as erythrocyte sedimentation rate and baseline levels of fibrinogen and high-sensitivity C reactive protein were predictive of stroke.

However, concluded Dr. Cavusoglu, "the finding that C4 predicted risk independently from these nonspecific markers of inflammation, suggests that measurement of C4 may add prognostic value above and beyond markers of acute-phase response in patients with known or suspected coronary artery disease."

Source: Reuters
Author: David Douglas

For more information: www.ajconline.org


Related Content

Technology | Blood Testing

October 9, 2019 β€” Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received ...

Home October 09, 2019
Home
News | Blood Testing

September 18, 2019 β€” Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...

Home September 18, 2019
Home
News | Blood Testing

March 19, 2019 β€” Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven ...

Home March 19, 2019
Home
News | Blood Testing

December 28, 2018 β€”Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche ...

Home December 28, 2018
Home
News | Blood Testing

October 26, 2018 β€” For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians ...

Home October 26, 2018
Home
News | Blood Testing

October 24, 2018 β€” For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes ...

Home October 24, 2018
Home
News | Blood Testing

October 16, 2018 β€” Abbott announced that its High Sensitive Troponin-I blood test has received CE Mark for distribution ...

Home October 16, 2018
Home
News | Blood Testing

September 4, 2018 β€” Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral ...

Home September 04, 2018
Home
News | Blood Testing

August 6, 2018 β€” A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency ...

Home August 06, 2018
Home
News | Blood Testing

March 26, 2018 β€” Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex ...

Home March 26, 2018
Home
Subscribe Now